These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 38104928)
1. Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis. Hensman J; Hahn LC; van Schooneveld MJ; Diederen RMH; Ten Brink JB; Florijn RJ; Bergen AA; Strubbe I; Heutinck P; van Genderen MM; van den Born LI; Thiadens AA; de Zaeytijd J; Leroy BP; Hoyng CB; Boon CJF Ophthalmol Retina; 2024 Jun; 8(6):600-606. PubMed ID: 38104928 [TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: effects on macular morphology and function. Testa F; Di Iorio V; Gallo B; Marchese M; Nesti A; De Rosa G; Melillo P; Simonelli F Ophthalmic Genet; 2019 Jun; 40(3):207-212. PubMed ID: 31149861 [No Abstract] [Full Text] [Related]
3. Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis. Verbakel SK; van de Ven JP; Le Blanc LM; Groenewoud JM; de Jong EK; Klevering BJ; Hoyng CB Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5143-5147. PubMed ID: 27699410 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Genead MA; Fishman GA; Walia S Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541 [TBL] [Abstract][Full Text] [Related]
5. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity. Andreuzzi P; Fishman GA; Anderson RJ Retina; 2017 Aug; 37(8):1555-1561. PubMed ID: 27828908 [TBL] [Abstract][Full Text] [Related]
6. STRUCTURAL AND FUNCTIONAL MONITORING OF EXTRAMACULAR CYSTOID SPACES IN A CASE OF X-LINKED RETINOSCHISIS TREATED WITH ACETAZOLAMIDE. Collison FT; Fishman GA Retin Cases Brief Rep; 2018 Fall; 12(4):318-321. PubMed ID: 27984356 [TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors limit complications in X-linked retinoschisis. Wey S; Brill DA; Miraldi Utz V; Sisk RA Front Med (Lausanne); 2023; 10():1281068. PubMed ID: 38020097 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis. Huang Q; Chen R; Lin X; Xiang Z PLoS One; 2017; 12(10):e0186180. PubMed ID: 29023491 [TBL] [Abstract][Full Text] [Related]
9. Use of dorzolamide for patients with X-linked retinoschisis. Apushkin MA; Fishman GA Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845 [TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Patients With X-Linked Retinoschisis During 18 Months. Pennesi ME; Birch DG; Jayasundera KT; Parker M; Tan O; Gurses-Ozden R; Reichley C; Beasley KN; Yang P; Weleber RG; Bennett LD; Heckenlively JR; Kothapalli K; Chulay JD; For The Xlrs-Study Group Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5941-5956. PubMed ID: 30551202 [TBL] [Abstract][Full Text] [Related]
11. Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors. Strong SA; Hirji N; Quartilho A; Kalitzeos A; Michaelides M Br J Ophthalmol; 2019 Feb; 103(2):233-237. PubMed ID: 29706600 [TBL] [Abstract][Full Text] [Related]
12. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child. Bušić M; Bjeloš M; Bosnar D; Ramić S; Bušić I Doc Ophthalmol; 2016 Feb; 132(1):67-73. PubMed ID: 26803827 [TBL] [Abstract][Full Text] [Related]
13. Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. Iannaccone A; Fung KH; Eyestone ME; Stone EM Am J Ophthalmol; 2009 Feb; 147(2):307-312.e2. PubMed ID: 18835469 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Liew G; Moore AT; Webster AR; Michaelides M Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491 [TBL] [Abstract][Full Text] [Related]
15. TOPICAL CARBONIC ANHYDRASE INHIBITORS IN THE LONG-TERM TREATMENT OF JUVENILE X-LINKED RETINOSCHISIS. Schmitt MA; Wang K; DeBenedictis MJ; Traboulsi EI Retina; 2022 Nov; 42(11):2176-2183. PubMed ID: 35982512 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Grover S; Fishman GA; Fiscella RG; Adelman AE Retina; 1997; 17(3):222-31. PubMed ID: 9196934 [TBL] [Abstract][Full Text] [Related]
17. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA. Dwivedi R; Tiroumal S Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos-Related Macular Cystoid Lesions: A Case Series. Durmaz Engin C; Ekinci UB; Selver A; Saatci AO Turk J Ophthalmol; 2020 Mar; 50(1):44-49. PubMed ID: 32167263 [TBL] [Abstract][Full Text] [Related]
19. X-linked retinoschisis maculopathy treated with topical dorzolamide, and relationship to genotype. Khandhadia S; Trump D; Menon G; Lotery AJ Eye (Lond); 2011 Jul; 25(7):922-8. PubMed ID: 21527955 [TBL] [Abstract][Full Text] [Related]
20. A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis. Rocha Cabrera P; Pareja Ríos AC; Cordovés Dorta L; Mantolán Sarmiento C; Serrano García MA Arch Soc Esp Oftalmol; 2014 Aug; 89(8):320-3. PubMed ID: 24269421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]